Aspirin in the prevention of cardiovascular disease for people with diabetes: uncertainties and opportunities

Guillaume Marquis-Gravel MD
Assistant Professor
Department of Medicine and Medical Specialties
Faculty of Medicine
Université de Montréal

This conference is organized by Rémi Rabasa-Lhoret. It is part of the 2021-2022 IRCM conference calendar.

Zoom Link : https://zoom.us/j/95269762104
ID : 952 6976 2104
Code : 476372

About the conference:
The role of aspirin in primary and secondary prevention of atherosclerotic cardiovascular disease has been redefined in recent years by large-scale, randomized studies. Platelets in diabetic patients present a higher potential for thrombosis and respond differently to aspirin compared to platelets in non-diabetic patients. In this conference, I will present the mechanistic, translational and clinical implications of diabetes in the use of aspirin for cardiovascular prevention.

About Guillaume Marquis-Gravel:
Dr. Guillaume Marquis-Gravel is an assistant professor in the Department of Medicine and Medical Specialties of the Université de Montréal and a specialist of interventional cardiology at the Montreal Heart Institute. His work is supported by a Junior 1 – Clinical Research Scholarship from the Fonds de recherché du Québec en santé (FRQS), a Bursary for Young Investigators of the Department of Medicine of the Université de Montréal and a Grant from the Montreal Heart Institute Foundation. Dr. Marquis-Gravel has published close to 70 scientific articles, book chapters and reviews, which are accessible here.

To make sure you don't miss any of the IRCM conferences, sign up now for our newsletter!